Top Markets
#1 Black Phoenix Black Phoenix +21,321.25%
#2 Nesa Nesa +767.20%
#3 Cortex Cortex +67.67%
#4 Kinesis Silver Kinesis Silver +55.16%
#5 QuantixAI QuantixAI +23.76%
#6 EXOD EXOD +22.78%
#7 Cash Cat Cash Cat +16.11%
#8 Derive Derive +14.05%
#9 Bless Bless +14.01%
#10 Pons Pons +13.84%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Caliway Biopharmaceuticals Co. L Caliway Biopharmaceuticals Co. L

Caliway Biopharmaceuticals Co. L

6919
Rang in Aktien #3557
Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated... Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated to developing pharmaceuticals primarily in the fields of aesthetic medicine and chronic inflammation. Its lead investigational drug, CBL-514, is currently undergoing Phase 2 clinical trials, targeting non-surgical fat reduction, Dercum's disease, and cellulite. Beyond this, the firm is also progressing CBA-539 through preclinical exploration for potential applications in central obesity, hyperpigmentation, and skin aging. The company's offerings also extend to dietary supplements. Established in 2012, Caliway Biopharmaceuticals operates from its headquarters in New Taipei City, Taiwan.
Aktienkurs
$3.28
Zuletzt synchronisiert: 2026-07-31
Marktkapitalisierung
$5.10B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-49.70%
Land
TW
Handel Caliway Biopharmaceuticals Co. L (6919)

Kategorie

Healthcare
EPS für Caliway Biopharmaceuticals Co. L (6919)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Caliway Biopharmaceuticals Co. L beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Caliway Biopharmaceuticals Co. L von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH